Breast Cancer Canada, AstraZeneca and Illumina are offering a $150K CDN research grant for innovations towards breast cancer screening and detection. This new partnership has been formed to drive progress on screening and detection of breast cancer. There is $100K CDN in funding available to Canadian research teams who are developing novel technology in the… Read more »
Breast Cancer Canada, AstraZeneca and Illumina are offering a $150K CDN research grant for innovations towards breast cancer screening and detection. This new partnership has been formed to drive progress on screening and detection of breast cancer. There is $100K CDN in funding available to Canadian research teams who are developing novel technology in the… Read more »
This is a collaboration between the CIHR-Institute of Circulatory and Respiratory Health (CIHR-ICRH), Canadian Allergy, Asthma and Immunology Foundation (CAAIF), AstraZeneca Canada and AllerGen. The goal of this exciting funding opportunity is to support Canadian Allergists, Clinical Immunologists, MD clinician scientists and basic scientists working in translational research to pursue academic research in allergic asthma…. Read more »
This program is made possible by a partnership between the Canadian Lung Association (CLA), CIHR-Institute of Circulatory and Respiratory Health (CIHR-ICRH) and AstraZeneca Canada (AZ Canada). The goal of the award is to support Emerging Clinician Scientists (e.g., Doctor of Medicine, Doctor of Medicine with graduate research training, Doctor of Dental Sciences, PhD-Respiratory Therapist, PhD-Registered… Read more »
This program is made possible by a partnership between the Canadian Lung Association (CLA), CIHR-Institute of Circulatory and Respiratory Health (CIHR-ICRH) and AstraZeneca Canada (AZ Canada). The goal of the award is to support Emerging Clinician Scientists (e.g., Doctor of Medicine, Doctor of Medicine with graduate research training, Doctor of Dental Sciences, PhD-Respiratory Therapist, PhD-Registered… Read more »